Structure-based design of estrogen receptor-beta selective ligands

Area of Science:

• Medicinal Chemistry
• Structural Biology
• Computational Chemistry

Background:

• Estrogen receptors (ERs) play critical roles in physiology and disease.
• Selective targeting of ERalpha and ERbeta is crucial for therapeutic intervention.
• Developing ERbeta-selective ligands remains a challenge due to high sequence homology between ERalpha and ERbeta.

Purpose of the Study:

• To present the structure-based optimization of novel ERbeta-selective ligands.
• To elucidate the structural basis for selectivity using X-ray crystallography and molecular modeling.
• To understand the mechanism of selectivity enhancement through quantum chemical calculations.

Main Methods:

• Structure-based drug design and optimization of ERbeta-selective ligands.
• X-ray cocrystallography to determine ligand-ERalpha and ligand-ERbeta complex structures.
• Molecular modeling and quantum chemical calculations to analyze binding interactions and selectivity.

Main Results:

• Cocrystal structures revealed key interactions driving selectivity.
• Molecular modeling successfully exploited subtle differences in the ERalpha and ERbeta binding cavities.
• Optimized ligands achieved >100-fold selectivity for ERbeta over ERalpha in binding assays.
• Minimal residue substitutions in the ligand binding pocket were sufficient for high selectivity.

Conclusions:

• Structure-based design is effective for developing highly selective ERbeta ligands.
• Understanding subtle binding pocket differences is key to achieving selective ER targeting.
• These findings provide a foundation for developing novel therapeutics targeting ERbeta-mediated pathways.